GNTA
Genenta Science SPA
$
4.165
- Overview
- Forecast
- Valuation
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
4.250
Open
4.000
VWAP
4.13
Vol
1.05K
Mkt Cap
76.18M
Low
4.000
Amount
4.33K
EV/EBITDA(TTM)
--
Total Shares
18.22M
EV
66.27M
EV/OCF(TTM)
--
P/S(TTM)
--
Genenta Science SpA is an Italy-based company engaged in clinical-stage biotechnology research. The Company focuses on the development of lentivirus-based gene and cell therapies in cancer. It uses gene-based cytokine delivery to activate the immune system within the tumor providing the anti-tumor response. The Company not only operates locally but also is present in global markets, including the United States.
Show More
Valuation Metrics
The current forward P/E ratio for Genenta Science SPA (GNTA.O) is -5.43, compared to its 5-year average forward P/E of -9.70. For a more detailed relative valuation and DCF analysis to assess Genenta Science SPA 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
-9.70
Current PE
-5.43
Overvalued PE
-3.96
Undervalued PE
-15.44
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
-5.67
Current EV/EBITDA
-1.94
Overvalued EV/EBITDA
-0.27
Undervalued EV/EBITDA
-11.07
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
31.04
Current PS
0.00
Overvalued PS
94.95
Undervalued PS
-32.87
Financials
Annual
Quarterly
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
GNTA News & Events
Events Timeline
2025-05-07 (ET)
2025-05-07
07:28:25
Genenta Science, Anemocyte announce collaboration
2025-03-19 (ET)
2025-03-19
09:31:57
Genenta Science announces EUR 20M financing to expand pipeline
2025-01-09 (ET)
2025-01-09
05:46:06
Genenta Science announces amendment to pact with AGC Biologics
Sign Up For More Events
Sign Up For More Events
News
7.5
05-07NewsfilterGenenta and Anemocyte announce a collaboration for the manufacturing of starting materials for cutting-edge cell-based therapies
7.5
04-15NewsfilterGenenta Showcases Strategic Vision at Premier Biotech Forum in Qatar
7.5
01-09NewsfilterGenenta Strengthens Agreement with AGC Biologics to Boost Cell Therapy Manufacturing
Sign Up For More News
People Also Watch
LXRX
Lexicon Pharmaceuticals Inc
0.673
USD
-3.99%
ELDN
Eledon Pharmaceuticals Inc
2.880
USD
-0.35%
MTA
Metalla Royalty & Streaming Ltd
2.900
USD
-5.23%
SBT
Sterling Bancorp Inc
4.840
USD
-0.82%
ATOM
Atomera Inc
6.920
USD
+7.45%
ZYXI
Zynex Inc
2.140
USD
+3.38%
CPSS
Consumer Portfolio Services Inc
9.645
USD
+3.16%
FDBC
Fidelity D&D Bancorp Inc
41.290
USD
+2.35%
GENC
Gencor Industries Inc
13.460
USD
+0.90%
GRRR
Gorilla Technology Group Inc
17.560
USD
+8.87%
FAQ
What is Genenta Science SPA (GNTA) stock price today?
The current price of GNTA is 4.165 USD — it has decreased -4.03 % in the last trading day.
What is Genenta Science SPA (GNTA)'s business?
What is the price predicton of GNTA Stock?
What is Genenta Science SPA (GNTA)'s revenue for the last quarter?
What is Genenta Science SPA (GNTA)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Genenta Science SPA (GNTA)'s fundamentals?
How many employees does Genenta Science SPA (GNTA). have?